Synapse - Miguel-Angel Perales

Results (942)

Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with newly diagnosed and relapsed acute leukemia

Meeting Abstract

Nath, K.; Lee, J.; Elko, T. A.; Levy, L.; Preston, E.; Devlin, S. M.; Ponce, D. M.; Lin, R. J.; Shaffer, B. C.; Cho, C.; more...
Blood (2022)

Fulltext@MSK | Save

Multicenter phase I study of post-transplant low-dose inotuzumab ozogamicin to prevent relapse of acute lymphoblastic leukemia

Meeting Abstract

Metheny, L.; Sobecks, R. M.; Cho, C.; Wang, J.; Ciarrone, L.; Caimi, P. F.; Otegbeye, F.; Cooper, B. W.; Gallogly, M.; Malek, E.; more...
Blood (2022)

Fulltext@MSK | Save

Population pharmacokinetic model identifies an optimal fludarabine exposure for improved outcomes after CD19-directed CAR T cell therapy for aggressive B-NHL: Analysis from the Cell Therapy Consortium

Meeting Abstract

Scordo, M.; Flynn, J. R.; Devlin, S. M.; Gonen, M.; Parascondola, A.; Tomas, A. A.; Shouval, R.; Brower, J.; Porter, D. L.; Schuster, S. J.; more...
Blood (2022)

Fulltext@MSK | Save

Outcomes of subsequent anti-lymphoma therapies in patients (pts) with large B-cell lymphoma (LBCL) treated with axicabtagene ciloleucel (axi-cel) or standard of care (SOC) in the second-line (2L) ZUMA-7 study

Meeting Abstract

Ghobadi, A.; Munoz, J.; Westin, J.; Locke, F. L.; Miklos, D. B.; Rapoport, A. P.; Perales, M. A.; Reagan, P. M.; McGuirk, J. P.; Jacobson, C. A.; more...
Blood (2022)

Fulltext@MSK | Save

Microbial bile acid metabolism shapes effector T cell responses during inflammation in mouse and human

Meeting Abstract

Lindner, S.; Miltiadous, O.; Ramos, R. J.; Dai, A.; Kousa, A.; Armijo, G. K.; Ghale, R.; Nguyen, C. L.; Paredes Sanchez, J.; Fei, T.; more...
Blood (2022)

Fulltext@MSK | Save

Predictors and outcomes of immune effector cell associated neurotoxicity syndrome in patients receiving chimeric antigen receptor T-cell therapy for aggressive B-cell non-Hodgkin lymphoma

Meeting Abstract

Patel, V.; Bhaskar, S.; Schuster, S. J.; Nastoupil, L. J.; Perales, M. A.; Shouval, R.; McGuirk, J. P.; Maziarz, R. T.; Chen, A.; Bachanova, V.; more...
Blood (2022)

Fulltext@MSK | Save

Inflammatory biomarker clusters are predictive of response and toxicity in large B-cell lymphoma treated with CD19 CAR-T cell therapy

Meeting Abstract

Raj, S.; Perales, M. A.; Fein, J. A.; Tomas, A. A.; Batlevi, C. L.; De Lapuerta, M. C.; Dahi, P. B.; Danylesko, I.; Fried, S.; Funnell, T.; more...
Blood (2022)

Fulltext@MSK | Save

Post-transplant cyclophosphamide, tacrolimus, and mycophenolate mofetil as the new standard for graft-versus-host disease (GVHD) prophylaxis in reduced intensity conditioning: Results from phase III BMT CTN 1703

Meeting Abstract

Holtan, S. G.; Hamadani, M.; Wu, J.; Al Malki, M. M.; Runaas, L.; Elmariah, H.; Rezvani, A. R.; Gooptu, M.; Larkin, K. T.; Shaffer, B. C.; more...
Blood (2022)

Fulltext@MSK | Save

Extended-duration letermovir prophylaxis for cytomegalovirus infection after cord blood transplantation in adults

Journal Article

Politikos, I.; Lau, C.; Devlin, S. M.; Quach, S.; Lin, A.; Perales, M. A.; Shah, G. L.; Seo, S. K.; Papanicolaou, G. A.; Barker, J. N.
Blood Advances (2022)

Fulltext@MSK | Save

Racial disparities in access to alternative donor allografts persist in the era of "donors for all"

Research Letter

Fingrut, W. B.; Gyurkocza, B.; Davis, E.; Flynn, J.; Chinapen, S.; Naputo, K. A.; Quach, S.; Cho, C.; Giralt, S. A.; Jakubowski, A. A.; more...
Blood Advances (2022)

Fulltext@MSK | Save